Melanoma News Today

    Skip to content
    • Home
    • About Melanoma
    • Keytruda (Pembrolizumab)
    • Melanoma Clinical Trials
    • Contact Us
    March 25, 2015March 25, 2015

    UCLA Researchers Develop Effective Triple Combination Therapy for Melanoma

    Melanoma, News
    Researchers at the University of California, Los Angeles (UCLA) recently published in the journal Science Translational Medicine results of a groundbreaking effective triple combination therapy for advanced melanoma. The study is ... Read more
    March 24, 2015March 24, 2015

    How Advanced Melanoma Treatments Can Improve Patient Survival

    Melanoma, News
    When melanoma is detected early, treatment can be highly successful. However, survival rates decrease significantly when cancer cells spread to the lymph nodes and other organs. In the last 5 years, targeted therapy and ... Read more
    March 23, 2015March 23, 2015

    Melanoma Mortality Expected to Vanish in Light-Skinned Populations by 2050

    News
    A reduction in the mortality rate of cutaneous malignant melanoma, the most lethal form of skin cancer, is on the horizon for light-skinned populations, a recent study published in the ... Read more
    March 20, 2015March 20, 2015

    Research Shows Standard Treatments Not Effective Against Nodal in Metastatic Melanoma

    Melanoma, News
    A recent study published in Molecular Cancer Research, led by researchers from the laboratory of Mary J.C. Hendrix, found that standard treatments to address metastatic melanoma are ineffective against Nodal, a growth factor protein. ... Read more
    March 19, 2015March 19, 2015

    Novel Immunotherapy Drug Pembrolizumab ‘Fast-Tracked’ for Advanced Melanoma

    Melanoma, News
    Under a new United Kingdom Government scheme, the novel immunotherapy drug Pembrolizumab has become the first treatment ‘fast-tracked’ for National Health Service (NHS) patients with advanced melanoma. “It’s a step ... Read more
    March 18, 2015March 18, 2015

    Macrophages – The Missing Link in Melanoma Resistance to BRAF Therapy

    News
    In a new study entitled “BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth,” researchers suggest that a specific type of immune cell — macrophages — offers a potential new therapeutic ... Read more
    March 17, 2015March 17, 2015

    Researchers Discover Genetic Alterations in Children and Adolescents with Melanoma

    Melanoma, News
    Researchers from the St. Jude Children’s Research Hospital — Washington University Pediatric Cancer Genome Project were able to identify the genetic foundations of three different pediatric melanoma subtypes. These new ... Read more
    March 16, 2015March 16, 2015

    DermSpectra Nikon D810 Camera Integration Provides a High Resolution Skin Imaging Solution

    Melanoma, News
    DermSpectra — a startup firm specializing in the field of digital medical imaging systems — has announced a new OEM relationship with Japanese photography and optics Nikon Inc. Under terms ... Read more
    March 13, 2015March 13, 2015

    Delcath Submits Findings of Phase 3 Trial In Top Peer-reviewed Journal

    Melanoma, News
    Delcath Systems, Inc. a specialty pharmaceutical and device company with a primary focus on developing treatments for primary and metastatic liver cancer recently announced the publication of their Phase 3 ... Read more
    March 11, 2015March 12, 2015

    TGF-β Signals Can Influence Melanoma Cells’ Vulnerability To Drugs

    News
    A recent study published in Cell and titled “The Harmonies Played By TGF-β in Stem Cell Biology,” assessed how cancer cells respond to transforming growth factor beta (TGF-β) signals. These discoveries can lead to new approaches ... Read more
    March 11, 2015March 11, 2015

    Radiation Combined With Immunotherapy May Provide Optimal Response For Metastatic Melanoma

    Melanoma, News
    A new treatment strategy combining radiation therapy and two immunotherapies that target the CTLA4 and PD-1 pathways was recently shown to induce an optimal response in patients with metastatic melanoma. ... Read more
    March 10, 2015April 21, 2015

    FTC to Pursue Charges Against Melanoma Detection Apps

    Melanoma, News
    The Federal Trade Commission (FTC) has opened a case to end fraudulent advertisement regarding mobile apps that are supposed to diagnose melanoma through detecting symptoms or pictures of moles. While two marketers, MelApp ... Read more
    March 9, 2015March 9, 2015

    FDA Accepts Supplemental Biologics License Application for Yervoy as Adjuvant Treatment for Stage 3 Melanoma Patients

    Melanoma, News
    Bristol-Myers Squibb recently announced that the U.S. Food and Drug Administration (FDA) accepted the filing and review of the supplemental Biologics License Application (sBLA) for Yervoy (ipilimumab), a medication for the ... Read more
    March 6, 2015March 6, 2015

    Researchers Discover Pathway Responsible for Taste Loss in Skin Cancer Patients Under Chemotherapy Treatment

    News, Skin Cancer
    Researchers at the University of Michigan have recently discovered the molecular pathway that explains why patients under chemotherapy treatment experience changes in taste. The study was published in the Journal ... Read more
    March 5, 2015March 5, 2015

    Oleocanthal in Olive Oil Pokes Holes in Cancer Cells

    News, Skin Cancer
    Working in a laboratory at Rutgers University, Drs. Paul Breslin, David Foster, and Onica LeGendre discovered how a chemical component of olive oil kills human cancer cells derived from skin ... Read more
    March 4, 2015March 4, 2015

    Pioneering Blood-Based Biomarker Strategy Allows Early Cancer Detection in Mice

    Melanoma, News
    Researchers at Stanford University School of Medicine in California have recently revealed a new strategy for cancer detection via the use of blood-based biomarkers. The study is entitled “Detecting cancers ... Read more
    March 3, 2015March 3, 2015

    CURE OM Encourages Ocular Melanoma Patients to Share Stories

    Melanoma, News
    The Melanoma Research Foundation‘s Community United for Research and Education of Ocular Melanoma (CURE OM) program recently commended Oliver Sacks, a patient with ocular melanoma (OM), for sharing his experiences with the disease in ... Read more
    March 2, 2015March 2, 2015

    MD Anderson Studies Melanoma Patients Resistant To Therapy

    Melanoma, News
    Researchers from The University of Texas MD Anderson Cancer Center may have found a way to accurately predict which patients will be more likely to respond to genomic-based follow-up therapies by interpreting unique ... Read more
    February 26, 2015February 26, 2015

    Melanoma’s Addiction To Glutamine Explains Cancer Growth

    News
    Researchers from the Sanford-Burnham Medical Research Institute discovered that without a source of glutamine (one of the amino acids forming proteins) melanoma cells stop proliferating and die. Melanoma cells crave glutamine since they can overuse this essential nutrient as an ... Read more
    February 25, 2015February 25, 2015

    Decreased RNA-Editing Promotes Melanoma Progression

    Melanoma, News
    A new study entitled “Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis” showed how lack of RNA-editing, a key cellular process whereby RNA nucleotides are modified, contributes to tumor ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another melanoma update.

    * indicates required

    Recent Melanoma Articles

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • nevus mole prognosis BGB324

      New Clinical Trial Underway for Treatment of Advanced Melanoma

      May 25, 2017

    You May Also Like…..

    Opdivo, Yervoy Combo Improved Survival in Advanced Melanoma Phase 3 Trial

    April 6, 2017

    Opdivo, Yervoy combination

    Researchers Link Alcohol Consumption to Risk of Developing Invasive Melanoma

    December 13, 2016

    Alcohol consumption and melanoma

    Expert Panel Recommends National Guidelines to Improve Melanoma Screening

    March 28, 2017

    melanoma screening guidelines
    Visit Melanoma News Today's profile on Pinterest.
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • clinical trial results

      Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

      June 8, 2017

    • DecisionDx-Melanoma prognosis test

      New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

      June 6, 2017

    • Biothera presents trial results

      Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

      June 1, 2017

    • melanomas that resist immune response

      Researchers Provide New Insights into Melanoma Immune Resistance

      May 30, 2017

    • About Melanoma News Today
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Melanoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.